Dr. Eduardo Miranda, MD

Dr. Miranda practices at Harlingen VA Clinic in Harlingen, Texas.

Dr. Miranda's NPI, 1285673012, was assigned on June 6, 2006. Dr. Miranda graduated from Universidad Autonoma de Guadalajara in 1981. Dr. Miranda holds Texas license K8347.

Dr. Miranda's primary practice is Harlingen VA Clinic, at 2601 Veterans Dr, Harlingen, TX 78550. The practice phone is (615) 355-3451.

Dr. Miranda's primary practice is Harlingen VA Clinic in Harlingen, Texas. Dr. Miranda is also affiliated with Doctors Hospital of Laredo. The medical group on file is MCHD Physician Specialty Group-SPC. Dmand AI also links Dr. Miranda to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miranda practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Miranda's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Miranda is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Miranda's licenses on file in 3 states: Texas, Arizona and Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, lung cancer and lymphoma among the conditions Dr. Miranda treats.

CMS data shows 9,883 Medicare services from Dr. Miranda across 21 procedure codes in 2024, for 312 Medicare patients. Medicare paid $223,658 for them.

CMS counts 312 Medicare patients who saw Dr. Miranda in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miranda's median patient age at 69, with 67% women.

In 2024, Dr. Miranda wrote 1,382 Medicare Part D claims for 279 patients. 61% of them were for generic drugs. CMS names the drug for 1,066 of them, across 45 drugs with 11 or more claims each, at $6,278,387 in total drug cost. In 2023, CMS named 1,195 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Miranda for performance year 2024, reported individually. Dr. Miranda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Miranda as offering telehealth.

Dmand AI links 5 papers to Dr. Miranda, published from 2012 to 2021. 2019 was the busiest year, with 2. The most frequent topics are Penis. Dr. Miranda has published most often in J Sex Med. Dr. Miranda's most frequent co-author is John P. Mulhall, MD.

Dmand AI links Dr. Miranda to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Prostatic Neoplasms. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Miranda that name 2 trials.

CMS Open Payments shows 2,099 general payments to Dr. Miranda from 90 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,031. It also lists 2 research payments totaling $14,068 in 2021, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Miranda.

Dr. Miranda graduated from Universidad Autonoma de Guadalajara in 1981.

Dr. Miranda is in network with 22 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.